Arm Holdings
ARM Nasdaq Semiconductors Financials FY2022βFY2026
Arm Holdings' revenue rose 22.8% to $4.9 billion in fiscal 2026. Its operating margin was 18.3%, down from 20.7% a year earlier. Free cash flow was $979 million, up 450.0%. The diluted share count rose 0.5%.
Last close Β· Oct 23, 2026
$210.33
0.1%About these figures. Arm Holdings is a foreign company: it files an annual report on Form 20-F, prepared under US accounting standards (US GAAP), instead of a 10-K, and no quarterly reports, so this page has fiscal years only. Its shares trade in the US as American depositary shares (ADSs), and one ADS can stand for several ordinary shares, so per-share figures are per ordinary share and the page has no market value, P/E or valuation model.
What Arm Holdings does
No business description yet.
- Legal name
- ARM HOLDINGS PLC /UK
- Fiscal year ends
- March 31, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0001973239-26-000097
0001973239
Revenue and margins
Arm Holdings had $4.9B of revenue in fiscal 2026, up 22.8% on the year before.
Net income and earnings per share
From fiscal 2022 to 2026, diluted EPS grew 12.0% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $979M in fiscal 2026, 19.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Arm Holdings returned $0.0M to shareholders in fiscal 2026, 0% of free cash flow. The diluted share count rose 0.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably Arm Holdings can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.0B | $2.2B | $2.9B | $2.8B | $3.6B |
| Interest coverage | 633.0x | β | β | β | β |
| Current ratio | β | 2.6x | 2.8x | 5.2x | 6.0x |
| Quick ratio | β | 2.6x | 2.8x | 5.2x | 6.0x |
| Total assets | β | $6.9B | $7.9B | $8.9B | $10.7B |
| Total liabilities | β | $2.8B | $2.6B | $2.1B | $2.4B |
| Shareholders' equity | $3.5B | $4.1B | $5.3B | $6.8B | $8.3B |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β10.6% | 4.7% | β6.3% |
| Altman Z'' | 5.57 | 8.21 | 8.70 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Arm Holdings ARM | $224.6B | 22.8% | 18.3% | 19.9% | β | β | β | |
| Microchip Technology MCHP | $40.8B | 7.1% | 10.4% | 18.5% | 3.5% | 108.9x | 6 | Compare β |
| First Solar FSLR | $18.5B | 24.1% | 30.6% | 22.8% | 22.7% | 10.6x | 7 | Compare β |
| Skyworks Solutions SWKS | $12.6B | β2.2% | 12.2% | 27.1% | 8.5% | 43.2x | 5 | Compare β |
| ON Semiconductor ON | $29.2B | β15.4% | 1.4% | 23.7% | 0.9% | 46.6x | 5 | Compare β |
5 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $2.7B | $2.7B | $3.2B | $4.0B | $4.9B |
| Gross profit | $2.6B | $2.6B | $3.1B | $3.9B | $4.8B |
| Research and development | $995M | $1.1B | $2.0B | $2.1B | $2.8B |
| Operating income | $633M | $671M | $111M | $831M | $900M |
| Interest expense | $1.0M | $0.0M | $0.0M | β | β |
| Pretax income | $786M | $671M | $212M | $720M | $1.2B |
| Income tax | $110M | $147M | β$94.0M | β$72.0M | $253M |
| Net income | $549M | $524M | $306M | $792M | $904M |
| Diluted EPS | $0.54 | $0.51 | $0.29 | $0.75 | $0.85 |
| Diluted shares | 1.03B | 1.03B | 1.04B | 1.06B | 1.07B |
| Cash flow | |||||
| Cash from operations | $458M | $739M | $1.1B | $397M | $1.5B |
| Capital expenditure | $34.0M | $64.0M | $92.0M | $219M | $545M |
| Free cash flow | $424M | $675M | $998M | $178M | $979M |
| Depreciation and amortization | $185M | $170M | $162M | $183M | $249M |
| Stock-based compensation | $26.0M | $79.0M | $1.0B | $820M | $1.1B |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Balance sheet | |||||
| Cash and short-term investments | $1.0B | $2.2B | $2.9B | $2.8B | $3.6B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $25.0M | $59.0M |
| Current assets | β | $3.5B | $4.2B | $4.8B | $6.2B |
| Current liabilities | β | $1.4B | $1.5B | $929M | $1.0B |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | β | $185M | $215M | $354M | $772M |
| Total assets | β | $6.9B | $7.9B | $8.9B | $10.7B |
| Total liabilities | β | $2.8B | $2.6B | $2.1B | $2.4B |
| Shareholders' equity | $3.5B | $4.1B | $5.3B | $6.8B | $8.3B |
| Margins | |||||
| Gross margin | 95.2% | 96.0% | 95.2% | 97.0% | 97.5% |
| Operating margin | 23.4% | 25.1% | 3.4% | 20.7% | 18.3% |
| EBITDA margin | 30.3% | 31.4% | 8.4% | 25.3% | 23.4% |
| Net margin | 20.3% | 19.6% | 9.5% | 19.8% | 18.4% |
| FCF margin | 15.7% | 25.2% | 30.9% | 4.4% | 19.9% |
| Returns | |||||
| Return on capital employed | β | β | 1.9% | 11.5% | 10.2% |
| Return on equity | β | β | 6.6% | 13.1% | 12.0% |
| Return on assets | β | β | 4.1% | 9.4% | 9.2% |
| Growth | |||||
| Revenue growth | β | β0.9% | 20.7% | 23.9% | 22.8% |
| Net income growth | β | β4.6% | β41.6% | 158.8% | 14.1% |
| EPS growth | β | β5.6% | β43.1% | 158.6% | 13.3% |
| FCF growth | β | 59.2% | 47.9% | β82.2% | 450.0% |
| Share count change | β | 0.3% | 1.6% | 1.8% | 0.5% |
| Financial health | |||||
| Interest coverage | 633.0x | β | β | β | β |
| Current ratio | β | 2.6x | 2.8x | 5.2x | 6.0x |
| Quick ratio | β | 2.6x | 2.8x | 5.2x | 6.0x |
| Capital allocation | |||||
| Capex / revenue | 1.3% | 2.4% | 2.9% | 5.5% | 11.1% |
| Stock comp / revenue | 1.0% | 3.0% | 32.1% | 20.5% | 21.4% |
| Payouts / FCF | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Quality scores | |||||
| Altman Z'' | β | 5.4 | 5.6 | 8.2 | 8.7 |
| Accruals ratio | β | β | β10.6% | 4.7% | β6.3% |
Source: SEC EDGAR XBRL filings (CIK 0001973239). Data updated October 23, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.